Ligand Pharmaceuticals, Inc. (LGNXZ) Financials
Stock symbol LGNXZ is outdated, potentially delisted? Maybe it is available on other exchange?
LGNXZ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 1.6 billion | 543.4 million |
| Sept. 30, 2025 | 1.5 billion | 526.6 million |
| June 30, 2025 | 948.6 million | 120.1 million |
| March 31, 2025 | 905.4 million | 109.9 million |
LGNXZ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | 45.8 million | 14.3 million |
| Sept. 30, 2025 | 13.1 million | 14.7 million |
| June 30, 2025 | 15.6 million | 10.0 million |
| March 31, 2025 | -25.7 million | 7.8 million |
LGNXZ Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | 44.8 million |
| Sept. 30, 2025 | 117.3 million |
| June 30, 2025 | 4.8 million |
| March 31, 2025 | -42.5 million |
LGNXZ Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 733.5 million | 450.4 million | - |
| Sept. 30, 2025 | 664.5 million | 454.3 million | 4.4 million |
| June 30, 2025 | 245.0 million | 4.6 million | - |
| March 31, 2025 | 208.9 million | 3.6 million | - |
LGNXZ Shares Outstanding
LGNXZ Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 9000 | 3.5 million | 25.0 million | - |
| Sept. 30, 2025 | 15000 | 21.0 million | 28.4 million | - |
| June 30, 2025 | 214000 | 6.6 million | 20.2 million | - |
| March 31, 2025 | 214000 | 50.1 million | 18.8 million | - |
LGNXZ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 59.7 million | - |
| Sept. 30, 2025 | 115.5 million | 11.9 million |
| June 30, 2025 | 47.6 million | 11.2 million |
| March 31, 2025 | 45.3 million | 13.1 million |
LGNXZ Revenue by Segment
Graph available only for paid members. Upgrade to see it.
LGNXZ
Price: $0
52 week price:
Payout Ratio Range:
Exchange: PNK
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 47237